Laura Lovett
Also: RenalytixAI taps Thoma McLain as new CCO; Luba Greenwood announces departure from Verily.
The technology will be able to detect when a user's heart rate decreases to trigger the medication.
The program is designed to help providers gain additional insights into a patient's health records without changing their workflows.
The company closed its first day roughly 36% above its initial pricing of $28.
Greenwood, Verily's business development manager, discussed the importance of teaching the next generation about the convergence of industries within digital health.
MassBio's Luba Greenwood also discusses her decision to leave Verily in order to pursue teaching the intersection of life science and technology at Harvard.
Also: Liva Healthcare inks deal with Care City; SnapMD teams up with Carefluence on new platform.
A new study published in JMIR found that data from the devices could help identify college students living with loneliness.
Sweden-based Flow landed $1.5 million in funding from Khosla Ventures.
The social media giant teamed up with researchers from Stanford Lab for Mental Health Innovation to develop short digital exercises for stress.